Molecular targets in inhibition of hepatitis C virus replication

Antiviral Chemistry and Chemotherapy

Volumn 8, Issue 4, 1997, Pages 281-301

  Bartenschlager, R ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

HCV chemotherapy; HCV proteinase inhibitors; HCV replication; HCV specific antivirals; NS3 4A proteinase complex

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTIVIRUS AGENT; HELICASE; PROTEINASE; PROTEINASE INHIBITOR; RNA POLYMERASE; VIRUS ENZYME;

ARTICLE; BLOOD TRANSFUSION; CELL CULTURE; CHRONIC LIVER DISEASE; HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME; VIRUS REPLICATION;

EID: 0030862814     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029700800401     Document Type: Article

References (187)

1. Agrawal S, Ikeuchi T, Sun D, Sarin PS, Konopka A, Maizel J & Zamecnik PC (1989) Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues. Proceedings of the National Academy of Sciences, USA 86: 7790-7794.
2. Alt M, Renz R, Hofschneider PH, Paumgartner G & Caselmann WH (1995) Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides. Hepatology 22: 707-717.
3. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo Q-L & Kuo G (1989) Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with cute and chronic non-A, non-B hepatitis. New England Journal of Medicine 321: 1494-1500.
4. Asabe S-I, Tanji Y, Satoh S, Kaneko T, Kimura K & Shimotohno K (1997) The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation. Journal of Virology 71: 790-796.
5. Bartenschlager R, Ahlborn-Laake L, Mous J & Jacobsen H (1993) Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. Journal of Virology 67: 3835-3844.
6. Bartenschlager R, Ahlborn-Laake L, Mous J & Jacobsen H (1994) Kinetic and structural analyses of hepatitis C virus polyprotein processing. Journal of Virology 68: 5045-5055.
7. Bartenschlager R, Ahlborn-Laake L, Yasargil K, Mous J & Jacobsen H (1995a) Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase. Journal of Virology 69: 198-205.
8. Bartenschlager R, Lohmann V, Wilkinson T & Koch JO (1995b) Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. Journal of Virology 69: 7519-7528.
9. Behrens S-E, Tomei L & De Francesco R (1996) Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO Journal 15: 12-22.
10. Berger A & Schechter I (1970) Mapping the active site of papain with the aid of peptide substrates and inhibitors. Philosophical Transactions of the Royal Society London Series B 257: 249-264.
11. Bouffard P, Bartenschlager R, Ahlborn-Laake L, Mous J, Roberts N & Jacobsen H (1995) An in vitro assay for hepatitis C virus NS3 serine proteinase. Virology 209: 52-59.
12. Bradley D, McCaustland K, Krawczynski I, Speibring J, Humphrey C & Cook EH (1991) Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose. Journal of Medical Virology 34: 206-208.
13. Bukh J, Purcell RH & Miller RH (1993) At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proceedings of the National Academy of Sciences, USA 90: 8234-8238.
14. Butkiewicz NJ, Wendel M, Zhang R, Jubin R, Pichardo J, Smith EB, Hart AM, Ingram R, Durkin J, Mui PW, Murray MG, Ramanathan L & Dasmahapatra B (1996) Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A cofactor activity. Virology 225: 328-338.
15. Carrick RJ, Schlauder GG, Peterson DA & Mushawar IK (1992) Examination of the buoyant density of hepatitis C virus by the polymerase chain reaction. Journal of Virological Methods 39: 279-289.
16. Chambers TJ, Weir RC, Grakoui A, McCourt DW, Bazan JF, Fletterick RJ & Rice CM (1990) Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proceedings of the National Academy of Sciences, USA 87: 8898-8902.
17. Chemello L, Alberti A, Rose K & Simmonds P (1994) Hepatitis C serotype and response to interferon therapy. New England Journal of Medicine 330: 143.
18. Chen P-J, Lin M-H, Tai K-F, Liu P-C, Lin C-J & Chen D-S (1992) The Taiwanese hepatitis C virus genome: sequence determination and mapping the 5′ termini of viral genomic and antigenomic RNA. Virology 188: 102-113.
19. Choi HK, Tong L, Minor W, Dumas P, Boege U, Rossmann MG & Wengler G (1991) Structure of Sindbis virus core protein reveals a chymotrypsin-like serine proteinase and the organization of the virion. Nature 354: 37-43.
20. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW & Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
21. Choo Q-L, Richman K, Han J, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby A, Barr P, Weiner A, Bradley D, Kuo G & Houghton M (1991) Genetic organization and diversity of the hepatitis C virus. Proceedings of the National Academy of Sciences, USA 88: 2451-2455.
22. Choo S-H, So H-S, Cho JM & Ryu W-S (1995) Association of hepatitis C virus particles with immunoglobulin: a mechanism for persistent infection. Journal of General Virology 76: 2337-2341.
23. Chu M, Mierzwa R, Truumees I, King A, Patel M, Berrie R, Hart A, Butkiewicz N, Dasmahapatra B, Chan TM & Puar MS (1996) Structure of SCH 68631: a new hepatitis C virus proteinase inhibitor from Streptomyces sp. Tetrahedron Letters 40: 7229-7232.
24. Collett M (1992) Molecular genetics of pestiviruses. Comparative Immunology, Microbiology and Infectious Diseases 15: 145-154.
25. Colombo M, Kuo G, Choo Q-L, Donato MF, Ninno ED, Tommasini MA, Dioguardi N & Houghton M (1989) Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet ii: 1006-1008.
26. Cuthbert JA (1994) Hepatitis C: progress and problems. Clinical Microbiology Reviews 7: 505-532.
27. D'Souza ED, O'Sullivan E, Amphlett EM, Rowlands DJ, Sangar DV & Clarke BE (1994) Analysis of NS3-mediated processing of the hepatitis C virus non-structural region in vitro. Journal of General Virology 75: 3469-3476.
28. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer Jr HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Alberth J, Meschievitz C, Ortego TJ, Gibas A & The Hepatitis Interventional Therapy Group (1989) Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial. New England Journal of Medicine 321: 1501-1506.
29. De Francesco R, Urbani A, Nardi MC, Tomei L, Steinkühler C &. Tramontano A (1996) A zinc binding site in viral serine proteinases. Biochemistry 35: 13282-13287.
30. De Mitri MS, Poussin K, Baccarini P, Pontisso P, D'Errico A, Simon N, Grigioni W, Alberti A, Beaugrand M, Pisi E & Bréchot C (1995) HCV-associated liver cancer without cirrhosis. Lancet 345: 413-415.
31. Di Bisceglie AM, Shindo M, Fong TL, Fried MW, Swain MG, Gergasa NV, Axiotis CA, Waggoner JG, Park Y & Hoofnagle JH (1992) A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology 16: 649-654.
32. Dubuisson J, Hsu HH, Cheung RC, Greenberg HB, Russell DG & Rice CM (1994) Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. Journal of Virology 68: 6147-6160.
33. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, McIntyre N & Simmonds P (1994) Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 19: 13-18.
34. Eckart MR, Selby M, Masiarz F, Lee C, Berger K, Crawford C, Kuo C, Kuo G, Houghton M & Choo Q-L (1993) The hepatitis C virus encodes a serine proteinase involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochemical and Biophysical Research Communications 192: 399-406.
35. Elbers K, Tautz N, Becher P, Stoll D, Rümenapf T & Thiel HJ (1996) Processing in the pestivirus E2-NS2 region: identification of proteins p7 and E2p7. Journal of Virology 70: 4131-4135.
36. Erker JC, Simons JN, Muerhoff AS, LearyTP, Chalmers ML, Desai SM & Mushahwar IK (1996) Molecular cloning and characterization of a GB virus C isolate from a patient with non-A-E hepatitis. Journal of General Virology 77: 2713-2720.
37. Failla C, Tomei L & De Francesco R (1994) Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. Journal of Virology 68: 3753-3760.
38. Failla C, Tomei L & De Francesco R (1995) An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A. Journal of Virology 69: 1769-1777.
39. Failla CM, Pizzi E, De Francesco R & Tramontano A (1996) Redesigning the substrate specificity of the hepatitis C virus NS3 protease. Folding and Design 1: 35-42.
40. Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B & Purcell RH (1991) A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. New England Journal of Medicine 325: 98-104.
41. Filocamo G, Pacini L & Migliaccio G (1997) Chimeric Sindbis viruses dependent on the NS3 protease of hepatitis C virus. Journal of Virology 71: 1417-1427.
42. Fuller-Pace FV (1994) RNA helicases: modulator of RNA structure. Trends in Cell Biology 4: 271-274.
43. Gerber MA (1993) Relation of hepatitis C virus to hepatocellular carcinoma. Journal of Hepatology 17 (Supplement 3): 108-111.
44. Goodarzi G, Gross SC, Tewari A & Watabe K (1990) Antisense oligodeoxyribonucleotides inhibit the expression of the gene for hepatitis B virus surface antigen. Journal of General Virology 71: 3021-3025.
45. Gorbalenya AE, Koonin EV, Donchenko AP & Blinov VM (1989) Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes. Nucleic Acids Research 17: 4713-4730.
46. Grakoui A, Wychowski C, Lin C, Feinstone SM & Rice CM (1993a) Expression and identification of hepatitis C virus polyprotein cleavage products. Journal of Virology 67: 1385-1395.
47. Grakoui A, McCourt DW, Wychowski C, Feinstone SM & Rice CM (1993b) A second hepatitis C virus-encoded proteinase. Proceedings of the National Academy of Sciences, USA 90: 10583-10587.
48. Grakoui A, McCourt DW, Wychowski C, Feinstone SM & Rice CM (1993c) Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. Journal of Virology 67: 2832-2843.
49. Gretch DR, Polyak SJ, Wilson JJ, Carithers Jr RL, Perkins JD & Corey L (1996) Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. Journal of Virology 70: 7622-7631.
50. Gwack Y, Kim DW, Han JH & Choe J (1996) Characterization of RNA binding activity and RNA helicase activity of the hepatitis C virus NS3 protein. Biochemical and Biophysical Research Communications 225: 654-659.
51. Hahm B, Han DS, Back SH, Song O-K, Cho M-J, Kim C-J, Shimotohno K & Jang SK (1995) NS3-4A of hepatitis C virus is a chymotrypsin-like protease. Journal of Virology 69: 2534-2539.
52. Hahm B, Back SH, Lee TG, Wimmer E & Jang SK (1996) Generation of a novel poliovirus with requirement of hepatitis C virus protease NS3 activity. Virology 226: 318-326.
53. Hanecak R, Brown-Driver V, Fox MC, Azad RF, Furusako S, Nozaki C, Ford C, Sasmor H & Anderson KP (1996) Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes. Journal of Virology 70: 5203-5212.
54. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, Ito Y, Ishikawa T, Takayanagi M & Nagai Y (1993) Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 197: 659-668.
55. Hijikata M, Kato N, Ootsuyama Y & Nakagawa M (1991a) Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proceedings of the National Academy of Sciences, USA 88: 5547-5551.
56. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S & Shimotohno K (1991b) Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochemical and Biophysical Research Communications 175: 220-228.
57. Hijikata M, Shimizu YK, Kato H, Iwamoto K, Shih JW, Alter HJ, Purcell RH & Yoshikura H (1993a) Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. Journal of Virology 67: 1953-1958.
58. Hijikata M, Mizushima H, Tanji Y, Komoda Y, Hirowatari Y, Akagi T, Kato N, Kimura K & Shimotohno K (1993b) Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proceedings of the National Academy of Sciences, USA 90: 10733-10737.
59. Hijikata M, Mizushima H, Akagi T, Mori S, Kakiuchi N, Kato N, Tanaka T, Kimura K & Shimotohno K (1993c) Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. Journal of Virology 67: 4665-4675.
60. Hirowatari Y, Hijikata M, Tanji Y, Nyunoya H, Mizushima H, Kimura K, Tanaka T, Kato N & Shimotohno K (1993) Two proteinase activities in HCV polypeptide expressed in insect cells using baculovirus vector. Archives of Virology 133: 349-356.
61. Hirowatari Y, Hijikata M & Shimotohno K (1995) A novel method for the analysis of viral proteinase activity encoded by hepatitis C virus in cultured cells. Analytical Biochemistry 225: 113-120.
62. Honda M, Ping L-H, Rijnbrand RC, Amphlett E, Clarke B, Rowlands D & Lemon SM (1996) Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology 222: 31-42.
63. Hong Z, Ferrari E, Wright-Minogue J, Chase R, Risano C, Seelig G, Lee C-G & Kwong AD (1996) Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system. Journal of Virology 70: 4261-4268.
64. Houghton M (1996) Hepatitis C viruses. In Fields' Virology, 3rd edn. Edited by BN Fields & PM Knipe. Philadelphia: Lippincort-Raven, pp. 1035-1058.
65. Hüssy P, Langen H, Mous J & Jacobsen H (1996) Hepatitis C virus core protein: carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase. Virology 224: 93-104.
66. Hwang SB, Park K-J, Kim Y-S, Sung YC & Lai MMC (1997) Hepatitis C virus NS5B protein is a membrane-associated phosphoprotein with a predominantly perinuclear localization. Virology 227: 439-446.
67. Inchauspe G, Yebedee S, Lee D-H, Sugitani M, Nasoff M & Prince A (1991) Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proceedings of the National Academy of Sciences, USA 88: 10292-10296.
68. Jacobo-Molino A, Ding J, Nanni RG, Clark Jr AD, Lu X, Tantillo C, Williams RL, Kamer G, Ferris AL, Clark P, Hizi A, Hughes SH & Arnold E (1993) Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proceedings of the National Academy of Sciences, USA 90: 6320-6324.
69. Kaito M, Watanabe S, Tsukiyama-Kohara K, Yamaguchi K, Kobayashi Y, Konishi M, Yokoi M, Ishida S, Suzuki S & Kohara M (1994) Hepatitis C virus particle detected by immunoelectron microscopic study. Journal of General Virology 75: 1755-1760.
70. Kakiuchi N, Hijikata M, Komoda Y, Tanji Y, Hirowatari Y & Shimotohno K (1995) Bacterial expression and analysis of cleavage activity of HCV serine proteinase using recombinant and synthetic substrate. Biochemical and Biophysical Research Communications 210: 1059-1065.
71. Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M & Higashi Y (1993) A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C. Gastroenterology 105: 507-512.
72. Kaneko T, Tanji Y, Satoh S, Hijikata M, Asabe S, Kimura K & Shimotohno K (1994) Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochemical and Biophysical Research Communications 205: 320-326.
73. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T & Shimotohno K (1990) Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proceedings of the National Academy of Sciences, USA 87: 9524-9528.
74. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S & Shimotohno K (1993) Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. Journal of Virology 67: 3923-3930.
75. Kim DW, Gwack Y, Han JH & Choe J (1995) C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase. Biochemical and Biophysical Research Communications 215: 160-166.
76. Kim JL, Morgenstern KA, Lin C, Fox T, Dwyer MD, Landro JA, Chambers SP, Markland W, Lepre CA, O'Malley ET, Harbeson SL, Rice CM, Murcko MA, Caron PR & Thomson JA (1996) Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 87: 343-355.
77. Koch JO, Lohmann V, Herian U & Bartenschlager R (1996) In vitro studies on the activation of the hepatitis C virus NS3 proteinase by the NS4A cofactor. Virology 221: 54-66.
78. Kohlstaedt LA, Wang J, Friedman JM, Rice PA & Steitz TA (1992) Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256: 1783-1790.
79. Kolykhalov AA, Agapov EV & Rice CM (1994) Specificity of the hepatitis C virus NS3 protease: effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing. Journal of Virology 68: 7525-7533.
80. Kolykhalov AA, Feinstone SM & Rice CM (1996) Identification of a highly conserved sequence element at the 3′ terminus of hepatitis C virus genome RNA. Journal of Virology 70: 3363-3371.
81. Komoda Y, Hijikata M, Tanji Y, Hirowatari Y, Mizushima H, Kimura K & Shimotohno K (1994a) Processing of hepatitis C viral polyprotein in Escherichia coli. Gene 145: 221-226.
82. Komoda Y, Hijikata M, Sato S, Asabe S-I, Kimura K & Shimotohno K (1994b) Substrate requirements of hepatitis C virus serine proteinase for intermolecular polypeptide cleavage in Escherichia coli. Journal of Virology 68: 7351-7357.
83. Koonin EV & Dolja VV (1993) Evolution and taxonomy of positive-strand RNA viruses: implications of comparative analysis of amino acid sequences. Critical Reviews in Biochemistry and Molecular Biology 28: 375-430.
84. Koskinas J, Tibbs C, Saleh MG, Pereira LM, McFarlane IG & Williams R (1995) Effects of ribavirin on intrahepatic and extrahepatic expression of hepatitis C virus in interferon nonresponsive patients. Journal of Medical Virology 45: 29-34.
85. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redecker AG, Purcell RH, Myamura T, Dienstag JL, Alter MJ, Syevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee W-S, Kuo C, Berger K, Shister JR, Overby LR, Bradley DW & Houghton M (1989) An assay for circulating antibodies to a major etiologic virus of human non-A non-B hepatitis. Science 244: 362-364.
86. Lai M-Y, Kao J-H, Yang P-M, Wang J-T, Chen P-J, Chan K-W, Chu J-S & Chen D-S (1996) Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C. Gastroenterology 111: 1307-1312.
87. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM & Mushawar IK (1996) Sequence and genomic organization of GBV-C: a novel member of the Flaviviridae associated with human non-A-E hepatitis. Journal of Medical Virology 48: 60-67.
88. Leinbach SS, Bhat RA, Xia S-M, Hum W-T, Stauffer B, Davis AR, Hung PP & Mizutani S (1994) Substrate specificity of the NS3 serine proteinase of hepatitis C virus as determined by mutagenesis at the NS3/NS4A junction. Virology 204: 163-169.
89. Li JP & Baltimore D (1988) Isolation of poliovirus 2C mutants defective in viral RNA synthesis. Journal of Virology 62: 4016-4021.
90. Lieber A, He C-Y, Polyak SJ, Gretch DR, Barr D & Kay MA (1996) Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes. Journal of Virology 70: 8782-8791.
91. Lin C & Rice CM (1995) The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay. Proceedings of the National Academy of Sciences, USA 92: 7622-7626.
92. Lin C, Lindenbach BD, Pragai BM, McCourt DW & Rice CM (1994a) Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. Journal of Virology 68: 5063-5073.
93. Lin C, Pragai BM, Grakoui A, Xu J & Rice CM (1994b) Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. Journal of Virology 68: 8147-8157.
94. Lin C, Thomson JA & Rice CM (1995) A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro. Journal of Virology 69: 4373-4380.
95. Linnen J, Wages Jr J, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayannis P, Young L, Piatak Jr M, Hoover C, Fernandez J, Chen S, Zou J-C, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Foung SK, Thomas H, Bradley D, Margolis H & Kim JP (1996) Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271: 505-508.
96. Lohmann V, Koch JO & Bartenschlager R (1996) Processing pathways of the hepatitis C virus proteins. Journal of Hepatology 24 (Supplement 2): 11-19.
97. Love RA, Parge HE, Wickersham JA, Hostomsky Z, Habuka N, Moomaw EW, Adachi T & Hostomska Z (1996) The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural Zinc binding site. Cell 87: 331-342.
98. Lu H & Wimmer E (1996) Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosome entry site of hepatitis C virus. Proceedings of the National Academy of Sciences, USA 93: 1412-1417.
99. Lumbreras C, Delgado R, Fuertes A, Loinaz C, Iglesias J, Colina F, Aguado JM, Gimeno C, Garcia I, Lizasoain M, Moreno E & Noriega AR (1994) Clinical significance of hepatitis C virus (HCV) infection in liver transplant recipients - role of serology and HCV RNA detection. Digestive Diseases and Sciences 39: 965-969.
100. McDonnell WM & Lucey MR (1995) Hepatitis C infection. Current Opinion in Infectious Diseases 8: 384-390.
101. McOmish F, Chan SW, Dow BC, Gillon J, Frame WD, Crawford RJ, Yap PL, Follett EA & Simmonds P (1993) Detection of three types of differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion 33: 7-13.
102. McOmish F, Yap PL, Dow BC, Follett EA, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen R, Lin C, Lai C, Leong S, Medgyesi GA, Héjjas M, Kiyokawa H, Fukada K, Cuypers T, Saeed AA, Al-Rasheed AM, Lin M & Simmonds P (1994) Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. Journal of Clinical Microbiology 32: 884-892.
103. Manabe S, Fuke I, Tanishita O, Kaji C, Gomi Y, Yoshida S, Mori C, Takamizawa A, Yosida I & Okayama H (1994) Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. Virology 198: 636-644.
104. Marcellin P, Boyer N, Giostra E, Degott C, Courouce AM, Degos F, Cappere H, Cales P, Couzigou P & Benhamou JP (1991) Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology 13: 393-397.
105. Martell M, Esteban JI, Quer J, Genescà J, Weiner A, Esteban R, Guardia J & Gó mez J (1992) Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. Journal of Virology 66: 3225-3229.
106. Martell M, Esteban JI, Quer J, Vargas V, Esteban R, Guardia J & Gomez J (1994) Dynamic behaviour of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. Journal of Virology 68: 3425-3436.
107. Mast EE & Alter MJ (1993) Epidemiology of viral hepatitis: an overview. Seminars in Virology 4: 273-283.
108. Matsukura M, Shinozuka K, Zon G, Mitsuya H, Reitz M, Cohen JS & Broder S (1987) Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proceedings of the National Academy of Sciences, USA 84: 7706-7710.
109. Matsukura M, Zon G, Shinozuka K, Robert-Guroff M, Shimada T, Stein CA, Mitsuya H, Wong-Staal T, Cohen JS &. Broder S (1989) Regulation of viral expression of human immunodeficiency virus in vitro by an antisense oligodeoxynucleotide against rev (art/trs) in chronically infected cells. Proceedings of the National Academy of Sciences, USA 86: 4244-4248.
110. Matsumoto M, Hwang SB, Jeng K-S, Zhu N & Lai MM (1996) Homotypic interaction and multimerization of hepatitis C virus core protein. Virology 218: 43-51.
111. Matsuura Y, Harada S, Suzuki R, Watanabe Y, Inoue Y, Saito I & Miyamura T (1992) Expression of processed envelope protein of hepatitis C virus in mammalian and insect cell. Journal of Virology 66: 1425-1431.
112. Meyers G & Thiel H-J (1996) Molecular characterization of pestiviruses. Advances in Virus Research 47: 53-118.
113. Miller RH & Purcell RH (1990) Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus subgroups. Proceedings of the National Academy of Sciences, USA 87: 2057-2061.
114. Miyamoto H, Okamoto H, Sato K, Tanaka T & Mishiro S (1992) Extraordinarily low density of hepatitis C virus estimated by sucrose density centrifugation and polymerase chain reaction. Journal of General Virology 73: 715-718.
115. Mizushima H, Hijikata M, Asabe S-I, Hirota M, Kimura K & Shimotohno K (1994a) Two hepatitis C virus glycoprotein E2 products with different C termini. Journal of Virology 68: 6215-6222.
116. Mizushima H, Hijikata M, Tanji Y, Kimura K & Shimotohno K (1994b) Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2. Journal of Virology 68: 2731-2734.
117. Mizutani R, Kato N, Hirota M, Sugiyama K, Murakami A & Shimotohno K (1995) Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells. Biochemical and Biophysical Research Communications 212: 906-911.
118. Moriya K, Matsukura M, Kurokawa K & Koike K (1996) In vivo inhibition of hepatitis B virus gene expression by antisense phosphorothioate oligonucleotides. Biochemical and Biophysical Research Communications 218: 217-223.
119. Muerhoff AS, Leary TP, Simons JN, Pilot-Matias TJ, Dawson GJ, Erker JC, Chalmers ML, Schlauder GG, Desai SM & Mushawar IK (1995) Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. Journal of Virology 69: 5621-5630.
120. Murphy FA, Fauquet CM, Bishop DHL, Ghabrial SA, Jarvis AW, Martelli GP, Mayo MA & Summers MD (Editors) (1995) Classification and nomenclature of viruses. Sixth Report of the International Committee on Taxonomy of Viruses. Wien & New York: Springer Verlag, pp. 424-426.
121. Offensperger W-B, Offensperger S, Walter E, Teubner K, Igloi G, Blum HE & Gerok W (1993) In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides. EMBO Journal 12: 1257-1262.
122. Okamoto H, Kojima M, Sakamoto M, Iizuka H, Hadiwandowo S, Suwignyo S, Miyakawa Y & Mayumi M (1994) The entire nucleotide sequence and classification of a hepatitis C virus isolate of novel genotype from an Indonesian patient with chronic liver disease. Journal of General Virology 75: 629-635.
123. Overton H, McMillan D, Gillespie F & Mills J (1995) Recombinant baculovirus-expressed NS3 proteinase of hepatitis C virus shows activity in cell-based and in vitro assays. Journal of General Virology 76: 3009-3019.
124. Pizzi E, Tramontano A, Tomei L, LaMonica N, Failla C, Sardana M, Wood T & De Francesco R (1994) Molecular model of the specificity pocket of the hepatitis C virus protease: implications for substrate recognition. Proceedings of the National Academy of Sciences, USA 91: 888-892.
125. Poch O, Sauvaget I, Delarue M & Tordo N (1989) Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO Journal 8: 3867-3874.
126. Pozzato G, Moretti M, Franzin F, Croce LS, Tiribelli C, Masayu T, Kaneko S, Unoura M & Kobayashi K (1991) Severity of liver disease with different hepatitis C viral clones. Lancet 338: 509.
127. Ralston R, Thudium K, Berger K, Kuo C, Gervase B, Hall J, Selby M, Kuo G, Houghton M & Choo Q-L (1993) Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. Journal of Virology 67: 6753-6761.
128. Reed KE, Grakoui A & Rice CM (1995) Hepatitis C virus-encoded NS2-3 protease: cleavage-site mutagenesis and requirements for bimolecular cleavage. Journal of Virology 69: 4127-4136.
129. Reichard O, Yun ZB, Sönnerborg A & Weiland O (1993) Hepatitis C viral RNA titres in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C. Journal of Medical Virology 41: 99-102.
130. Reynolds JE, Kaminski A, Kettinen HJ, Grace K, Clarke BE, Carroll AR, Rowlands DJ & Jackson RJ (1995) Unique features of internal initiation of hepatitis C virus RNA translation. EMBO Journal 14: 6010-6020.
131. Rice CM (1996) Flaviviridae: the viruses and their replication. In Fields Virology, 3rd edn. Edited by BN Fields & PM Knipe. Philadelphia: Lippincott-Raven, pp. 931-959.
132. Rice CM, Lenches EM, Eddy SR, Shin SJ, Sheets RL & Strauss JH (1985) Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229: 726-733.
133. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo Q-L, Houghton M & Kuo G (1990) Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proceedings of the National Academy of Sciences, USA 87: 6547-6549.
134. Sakamoto M, Akahane Y, Tsuda F, Tanaka T, Woodfield DG & Okamoto H (1994) Entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a. Journal of General Virology 75: 1761-1768.
135. Santolini E, Migliaccio G & La Monica N (1994) Biosynthesis and biochemical properties of the hepatitis C virus core protein. Journal of Virology 68: 3631-3641.
136. Santolini E, Pacini L, Fipaldini C, Migliaccio G & La Monica N (1995) The NS2 protein of hepatitis C virus is a transmembrane polypeptide. Journal of Virology 69: 7461-7471.
137. Sato K, Okamoto H, Aihara S, Hoshi Y, Tanaka T & Mishiro S (1993) Demonstration of sugar moiety on the surface of hepatitis C virions recovered from the circulation of infected humans. Virology 196: 354-357.
138. Satoh S, Tanji Y, Hijikata M, Kimura K & Shimotohno K (1995) The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A. Journal of Virology 69: 4255-4260.
139. Schimid SR & Linder P (1992) D-E-A-D protein family of putative RNA helicases. Molecular Microbiology 6: 283-292.
140. Selby MJ, Choo Q-L, Berger K, Kuo G, Glazer E, Eckart M, Lee C, Chien D, Kuo C & Houghton M (1993) Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. Journal of General Virology 74: 1103-1113.
141. Selby MJ, Glazer E, Masiarz F & Houghton M (1994) Complex processing and protein:protein interactions in the E2:NS2 region of HCV. Virology 204: 114-122.
142. Shimizu YK, Feinstone SM, Kohara M, Purcell RH & Yoshikura H (1996a) Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology 23: 205-209.
143. Shimizu Y, Yamaji K, Masuho Y, Yokota T, Inoue H, Sudo K, Satoh S & Shimotohno K (1996b) Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease. Journal of Virology 70: 127-132.
144. Shimotohno K (1993) Hepatocellular carcinoma in Japan and its linkage to infection with hepatitis C virus. Seminars in Virology 4: 305-312.
145. Shoji I, Suzuki T, Chieda S, Sato M, Harada T, Chiba T, Matsuura Y & Miyamura T (1995) Proteolytic activity of NS3 serine proteinase of hepatitis C virus efficiently expressed in Escherichia coli. Hepatology 22: 1648-1654.
146. Simmonds P, Holmes EC, Cha T-A, Chan S-W, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J & Ureda MS (1993) Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. Journal of General Virology 74: 2391-2399.
147. Song O, Cho OH, Hahm B & Jang SK (1996) Development of an in vivo assay system suitable for screening inhibitors of hepatitis C viral protease. Molecules and Cells 6: 183-189.
148. Sousa R, Chung YJ, Rose JP & Wang B-C (1993) Crystal structure of bacteriophage T7 RNA polymerase at 3.3 Å resolution. Nature 364: 593-599.
149. Spaete RR, Alexander D, Rugroden M, Choo Q-L, Berger K, Crawford K, Kuo C, Leng S, Lee C, Ralston R, Thudium K, Tung JW, Kuo G & Houghton M (1992) Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology 188: 819-830.
150. Stein CA & Cheng Y-C (1993) Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 261: 1004-1012.
151. Steinkühler C, Tomei L & De Francesco R (1996a) In vitro activity of hepatitis C virus protease NS3 purified from recombinant baculovirus-infected Sf9 cells. Journal of Biological Chemistry 271: 6367-6373.
152. Steinkühler C, Urbani A, Tomei L, Biasiol G, Sardana M, Bianchi E, Pessi A & De Francesco R (1996b) Activity of purified hepatitis C virus protease NS3 on peptide substrates. Journal of Virology 70: 6694-6700.
153. Strauss JH & Strauss EG (1994) The alphaviruses: gene expression, replication, and evolution. Microbiology Reviews 58: 491-562.
154. Subramanya HS, Bird LE, Brannigan JA & Wigley DB (1996) Crystal structure of a DExx box DNA helicase. Nature 384: 379-383.
155. Suzich JA, Tamura JK, Palmer-Hill F, Warrener P, Grakoui A, Rice CM, Feinstone SM & Collett MS (1993) Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with related pestivirus and flavivirus enzymes. Journal of Virology 67: 6152-6158.
156. Suzuki T, Sato M, Chieda S, Shoji I, Harada T, Yamakawa Y, Watabe S, Matsuura Y & Miyamura T (1995) In vivo and in vitro trans-cleavage activity of hepatitis C virus serine proteinase expressed by recombinant baculoviruses. Journal of General Virology 76: 3021-3029.
157. Tai C-L, Chi W-K, Chen D-S & Hwang L-H (1996) The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). Journal of Virology 70: 8477-8484.
158. Tamura JK, Warrener P & Collett MS (1993) RNA-stimulated NTPase activity associated with the p80 protein of the pestivirus bovine viral diarrhea virus. Virology 193: 1-10.
159. Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, Nawata H, Ishibashi H, Maede Y, Kiyokawa H, Tokunaga K, Irita Y, Takeshita S, Arase Y & Nishino N (1991) Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Research 51: 2842-2847.
160. Tanaka T, Kato N, Cho M-J & Shimotohno K (1995) A novel sequence found at the 3′ terminus of hepatitis C virus genome. Biochemical and Biophysical Research Communications 215: 744-749.
161. Tanaka T, Kato N, Cho M-J, Sugiyama K & Shimotohno K (1996) Structure of the 3′ terminus of the hepatitis C virus genome. Journal of Virology 70: 3307-3312.
162. Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanaka T, Munekata E, Muchmore EE, Peterson DA & Mishiro S (1993) A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology 195: 297-301.
163. Tanji Y, Hijikata M, Hirowatari Y & Shimotohno K (1994a) Hepatitis C virus polyprotein processing: kinetics and mutagenic analysis of serine proteinase-dependent cleavage. Journal of Virology 68: 8418-8422.
164. Tanji Y, Hijikata M, Hirowatari Y & Shimotohno K (1994b) Identification of the domain required for trans-cleavage activity of hepatitis C viral serine proteinase. Gene 145: 215-219.
165. Tanji Y, Hijikata M, Satoh S, Kaneko T & Shimotohno K (1995a) Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. Journal of Virology 69: 1575-1581.
166. Tanji Y, Kaneko T, Satoh S & Shimotohno K (1995b) Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. Journal of Virology 69: 3980-3986.
167. Thomssen R, Bonk S, Propfe C, Heermann KH, Köchel HG & Uy A (1992) Association of hepatitis C virus in human sera with beta-lipoprotein. Medical Microbiology and Immunology 181: 293-300.
168. Thomssen R, Bonk S & Thiele A (1993) Density of heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Medical Microbiology and Immunology 182: 329-334.
169. Tomei L, Failla C, Santolini E, De Francesco R & La Monica N (1993) NS3 is a serine protease required for processing of hepatitis C virus polyprotein. Journal of Virology 67: 4017-4026.
170. Tomei L, Failla C, Vitale RL, Bianchi E & De Francesco R (1996) A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease. Journal of General Virology 77: 1065-1070.
171. Tsukiyama-Kohara K, Iizuka N, Kohara M & Nomoto A (1992) Internal ribosome entry site within hepatitis C virus RNA. Journal of Virology 66: 1476-1483.
172. Vidalin O, Major ME, Rayner B, Imbach J-L, Trépo C & Inchauspé G (1996) In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides. Antimicrobial Agents and Chemotherapy 40: 2337-2344.
173. von Ruden T & Gilboa E (1989) Inhibition of human T-cell leukemia virus type I replication in primary human T cells that express antisense RNA. Journal of Virology 63: 677-682.
174. Wakita T & Wands JR (1994) Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence. Journal of Biological Chemistry 269: 14205-14210.
175. Wang C, Sarnow P & Siddiqui A (1993) Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. Journal of Virology 67: 3338-3344.
176. Wang C, Le S, Ali N & Siddiqui A (1995) An RNA pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis C virus 5′ noncoding region. RNA 1: 526-537.
177. Warrener P & Collett MS (1995) Pestivirus NS3 (p80) protein possesses RNA helicase activity. Journal of Virology 69: 1720-1726.
178. Warrener P, Tamura JK & Collett MS (1993) RNA-stimulated NTPase activity associated with yellow fever virus NS3 protein expressed in bacteria. Journal of Virology 67: 989-996.
179. Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, Bonino F, Saracco G, Choo Q-L, Houghton M & Han JH (1991) Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180: 842-848.
180. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchinson J & Houghton M (1992) Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proceedings of the National Academy of Sciences, USA 89: 3468-3472.
181. Wengler G & Wengler G (1991) The carboxy-terminal part of the NS3 protein of West Nile flavivirus can be isolated as a soluble protein after proteolytic cleavage and represents an RNA-stimulated NTPase. Virology 184: 707-715.
182. Wu GY & Wu CH (1992) Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides. Journal of Biological Chemistry 267: 12436-12439.
183. Yadav PN, Yadav JS, Arnold E & Modak MJ (1994) A computer-assisted analysis of conserved residues in the three-dimensional structures of the polymerase domains of Escherichia coli DNA polymerase I and HIV-1 reverse transcriptase. Journal of Biological Chemistry 269: 716-720.
184. Yamada X, Tanihara NK, Takada A, Yorihuzi T, Tsutsumi M, Shimomura H, Tsuji T & Date T (1996) Genetic organization and diversity of the 3′ noncoding region of the hepatitis C virus. Virology 223: 255-261.
185. Yoo BJ, Spaete RR, Geballe AP, Selby M, Houghton M & Han JH (1992) 5′ end-dependent translation initiation of hepatitis C viral RNA and the presence of putative positive and negative translational control elements within the 5′ untranslated region. Virology 191: 889-899.
186. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M & Morishima T (1992) Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α-therapy: relationship to genotypes of hepatitis C virus. Hepatology 16: 293-299.
187. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P & Brechot C (1992) Infection of peripheral mononuclear blood cells by hepatitis C virus. Journal of Hepatology 15: 382-386.